Animal Core

动物核心

基本信息

项目摘要

The Animal Core will provide the main animal model (conditional Kras[G12D] mouse model) to all four projects. Heterozygous LSL-Kras[G12D/+] mice will be crossed with heterozygous Pdx-1-Cre mice. Offspring will be genotyped for the presence of the mutated Kras allele and Cre transgene using PCR analysis of mouse tail DNA. Mutant mice {LSL-Kras[G12D/+];Pdx-1-Cre) will be randomly allocated to either the control diet (AIN-76A) or the high fat, high calorie diet (HFCD). Each of the experimental groups will then be allocated to the individual project-specific treatments and interventions. The Animal Core will conduct all aspects related to the Project-specific animal studies. Cohorts of mice will be sacrificed at 3, 6, 9, and 12 months or prematurely terminated according to the institutional guidelines. At sacrifice, tissues, including the entire pancreas, other organs and blood will be harvested and processed. The exact post-processing procedures depend on the individual Project requirements and needs. In general, half of the pancreas will be fixed in formalin and embedded in paraffin (for standard histology and immunohistochemistry), the other half frozen in liquid nitrogen (for RNA and protein analysis). A small piece of the pancreas will be used for genotyping (to detect the successful recombination event). Included in the Animal Core is the Pathology Sub-Core, which will provide the histo-pathological evaluation of all mouse tissues. Services that the Animal Core provides for each Project include: Obtaining and maintaining institutional approval, designing the animal studies in terms of logistics and statistical power calculations (together with Project Pi's and Biostatistics Sub-Core), maintaining animal strains and setting up breeding pairs, genotyping of all animals, randomization of animals to experimental groups, preparation and administration of experimental diets or interventions, daily monitoring and animal care, euthanasia of animals, harvest of tissues and blood at sacrifice, processing tissue, e.g. fixing in formalin and embedding in paraffin, and sectioning (together with the Pathology Sub-Core), histopathological evaluation of tissue sections (together with the Pathology Sub- Core), generation of cell cultures (PanlNs and murine pancreatic cancer), storage of raw data, central banking of tissues and biological samples, distribution of tissues to individual Projects, discussion of results with Project Leaders, training of Project investigators in animal procedures (if desired).
动物核心将为所有四个项目提供主要动物模型(有条件的KRAS [G12D]小鼠模型)。杂合LSL-KRAS [G12D/+]小鼠将与杂合PDX-1-CRE小鼠交叉。将使用小鼠尾巴DNA的PCR分析,将后代用于突变的KRAS等位基因和CRE转基因的基因分型。突变小鼠{LSL-KRAS [G12D/+]; PDX-1-CRE)将随机分配给对照饮食(AIN-76A)或高脂肪,高卡路里饮食(HFCD)。然后,每个实验组将分配给各个项目特定的治疗和干预措施。动物核心将进行与特定于项目的动物研究有关的所有方面。小鼠队列将在3、6、9和12个月牺牲,或根据机构指南过早终止。在牺牲中,将收获和处理包括整个胰腺,其他器官和血液在内的组织。确切的后处理程序取决于单个项目的要求和需求。通常,一半的胰腺将固定在福尔马林中,并嵌入石蜡中(用于标准的组织学和免疫组织化学),另一半在液氮中冷冻(用于RNA和蛋白质分析)。一小部分胰腺将用于基因分型(检测成功的重组事件)。动物核心包括病理亚核,该病理将提供所有小鼠组织的组织病理评估。 Services that the Animal Core provides for each Project include: Obtaining and maintaining institutional approval, designing the animal studies in terms of logistics and statistical power calculations (together with Project Pi's and Biostatistics Sub-Core), maintaining animal strains and setting up breeding pairs, genotyping of all animals, randomization of animals to experimental groups, preparation and administration of experimental diets or interventions, daily monitoring and animal care, euthanasia of animals, harvest of牺牲时组织和血液,加工组织,例如fixing in formalin and embedding in paraffin, and sectioning (together with the Pathology Sub-Core), histopathological evaluation of tissue sections (together with the Pathology Sub- Core), generation of cell cultures (PanlNs and murine pancreatic cancer), storage of raw data, central banking of tissues and biological samples, distribution of tissues to individual Projects, discussion of results with Project Leaders, training of Project investigators in animal procedures (if需要)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guido Erwin Michael Eibl其他文献

Guido Erwin Michael Eibl的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guido Erwin Michael Eibl', 18)}}的其他基金

Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
  • 批准号:
    10409304
  • 财政年份:
    2022
  • 资助金额:
    $ 25.83万
  • 项目类别:
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
慢性压力和肥胖在胰腺癌进展中的相互作用
  • 批准号:
    10612088
  • 财政年份:
    2022
  • 资助金额:
    $ 25.83万
  • 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
  • 批准号:
    10398844
  • 财政年份:
    2020
  • 资助金额:
    $ 25.83万
  • 项目类别:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
肥胖促进的胰腺癌的化学预防和机制
  • 批准号:
    10605224
  • 财政年份:
    2020
  • 资助金额:
    $ 25.83万
  • 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
  • 批准号:
    10398845
  • 财政年份:
    2020
  • 资助金额:
    $ 25.83万
  • 项目类别:
Core 1: Animal and Cell Model Core
核心1:动物和细胞模型核心
  • 批准号:
    10605252
  • 财政年份:
    2020
  • 资助金额:
    $ 25.83万
  • 项目类别:
Core 1: Animal and Cell Model Core
核心1:动物和细胞模型核心
  • 批准号:
    10398850
  • 财政年份:
    2020
  • 资助金额:
    $ 25.83万
  • 项目类别:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
项目1:肥胖促进的胰腺癌中的脂肪组织炎症
  • 批准号:
    10605225
  • 财政年份:
    2020
  • 资助金额:
    $ 25.83万
  • 项目类别:
Inflammatory processes In diet-Induced pancreatic cancer promotion
饮食诱发的胰腺癌促进中的炎症过程
  • 批准号:
    8561427
  • 财政年份:
    2013
  • 资助金额:
    $ 25.83万
  • 项目类别:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
针对饮食诱导的 Kras 引发的胰腺癌的促进作用
  • 批准号:
    8337028
  • 财政年份:
    2012
  • 资助金额:
    $ 25.83万
  • 项目类别:

相似海外基金

Animal Core
动物核心
  • 批准号:
    8373952
  • 财政年份:
    2012
  • 资助金额:
    $ 25.83万
  • 项目类别:
Core--Animal Model, Analytical Chemistry and Biochemistry
核心--动物模型、分析化学和生物化学
  • 批准号:
    7457708
  • 财政年份:
    2007
  • 资助金额:
    $ 25.83万
  • 项目类别:
Minority Health International Research Training (MHIRT)
少数族裔健康国际研究培训 (MHIRT)
  • 批准号:
    7447789
  • 财政年份:
    1996
  • 资助金额:
    $ 25.83万
  • 项目类别:
Core--Animal Model, Analytical Chemistry and Biochemistry
核心--动物模型、分析化学和生物化学
  • 批准号:
    7644868
  • 财政年份:
  • 资助金额:
    $ 25.83万
  • 项目类别:
Animal Core
动物核心
  • 批准号:
    8712202
  • 财政年份:
  • 资助金额:
    $ 25.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了